This pro-inflammatory milieu activates pathways such as the NF-κB pathway, perpetuating chronic inflammation that underlies insulin resistance, metabolic syndrome, MASLD, and cardiovascular disease [3, 39–41]. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.